Lemonade stock
LMNDNYSELemonade, Inc., Financial ServicesISIN US52567D1072
22Score 22 out of 100, Weak
Price and trend
32 / 100
Price history
−44% in one yearThe chart shows daily closes over 6 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 24% below it.
Since April 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 46).
The price is 56% below its 52-week high. Largest decline in 6 years: 94% (January 2021 to April 2023).
Chart figures for advanced users
- SMA 50$45.74
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$56.36
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)46
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$39.28
- The lowest closing price of the last twelve months.
- Resistance$96.57
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Lemonade, Inc. belongs to the Insurance (Property & Casualty) industry (United States) and, with a market value of $3.35B, is number 34 of 58 companies in its industry on MEQIRI.
- In fiscal 2025 it reported a loss of $165.5M.
- For fiscal 2026, analysts expect on average adjusted earnings per share of −$1.85.
Show more
- MEQIRI Score 22 out of 100 (Weak): rank 973 of 976 in Financial Services, median 68.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- DilutionShare count up 30% since 2020.Capital allocation 18
- Loss-makingLoss of $144.6M over the last 12 months.Fundamentals 15
- Volatile share priceVolatility 71% a year over the last 12 months.Stability 8
The score is held back by profitability and stability.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 21 to 22.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredClosing price of 11 Nov 2026, used by the daily score.
No fair value can be calculated for this stock, so the signal follows the valuation grade.
Valuation metrics
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 62.9% on the twelve months before. Revenue has grown strongly since 2018, at around 65% per year. From 2018 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating −22%, net −22%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out. Last 12 months: net −13%. From 2018 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 18 Feb 2027in 98 days
- Last reported
- 5 Nov 2026EPS reported −$0.56 (expected −$0.58)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- −$1.85−0.4%
- Revenue
- $1.22B0.0%
- Earnings per share
- −$1.070.0%
- Revenue
- $1.64B0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: −21.8%Guidance for gross earned premium and revenue raised, while in-force premium and adjusted EBITDA guidance reiterated.
“Against that backdrop, we remain confident in our outlook and are reiterating our guidance across IFP and EBITDA while raising our guidance for both gross earned premium and revenue.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Jul 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 3 insiders sold, $7.43M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Peters John SheldonSale
4 Sept 2026, Chief Insurance Officer
- Shares
- 2,249
- Price
- $54.45
- Value
- $122,458
- Prosor MayaSale
3 Sept 2026, Chief Business Officer
- Shares
- 1,040
- Price
- $54.63
- Value
- $56,815
- Bixby Timothy ESale
3 Sept 2026, Chief Financial Officer
- Shares
- 1,893
- Price
- $54.63
- Value
- $103,415
Show 8 more
- Peters John SheldonSale
3 Sept 2026, Chief Insurance Officer
- Shares
- 859
- Price
- $54.63
- Value
- $46,927
- Peters John SheldonSale
13 Aug 2026, Chief Insurance Officer
- Shares
- 11,000
- Price
- $52.55
- Value
- $578,050
- Bixby Timothy ESale
7 Jul 2026, Chief Financial Officer
- Shares
- 73,000
- Price
- $79.18
- Value
- $5.78M
- Peters John SheldonSale
6 Jul 2026, Chief Insurance Officer
- Shares
- 3,444
- Price
- $79.00
- Value
- $272,076
- Peters John SheldonSale
4 Jun 2026, Chief Insurance Officer
- Shares
- 3,608
- Price
- $52.94
- Value
- $191,008
- Bixby Timothy ESale
3 Jun 2026, Chief Financial Officer
- Shares
- 2,227
- Price
- $53.17
- Value
- $118,410
- Peters John SheldonSale
3 Jun 2026, Chief Insurance Officer
- Shares
- 1,735
- Price
- $53.17
- Value
- $92,250
- Prosor MayaSale
3 Jun 2026, Chief Business Officer
- Shares
- 1,220
- Price
- $53.17
- Value
- $64,867
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Lemonade
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
976 rated companies in Financial Services
- This company
- 22
- Sector median
- 68
Categories against the sector medianMedian of 976 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Insurance (Property & Casualty)
The next larger and next smaller companies by market value
- Mercury GeneralMCY $4.78B66
- Accelerant HoldingsARX $4.32B37
- Palomar HoldingsPLMR $4.19B82
- Protector ForsikringPROT.OL $4.1B81
- Slide Insurance HoldingsSLDE $3.05B83
- Skyward Specialty Insurance GroupSKWD $2.8B74
- Porch GroupPRCH $2.53B36
- HCI GroupHCI $2.36B80
ETFs that hold Lemonade
Held by 12 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.10% | 0.30% | €2.17B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.09% | 0.30% | €4.22B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.04% | 0.43% | €2.48B |
Show 5 more
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.04% | 0.30% | €185.82M |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.03% | 0.45% | €1.53B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.02% | 0.35% | €434.1M |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.01% | 0.30% | €944.34M |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.01% | 0.25% | €175.89M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 17 Oct 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.